Abu Dhabi Wants to Own Longevity Biotech—and Juvenescence Is the Test Case
Abu Dhabi’s push to become a global life-sciences hub has
The anti-ageing bet on the liver: why longevity biotech’s first real drugs may start here
A new generation of biotech start-ups is trying to “rejuvenate”
A pill to live to 150? China’s grapeseed longevity hype gets right — and wrong
Lonvi Biosciences says its procyanidin C1 capsule could, one day,
From Crypto to Cytoplasm: Brian Armstrong’s NewLimit Targets Hepatocytes for Anti-Aging Breakthrough
In a biotech landscape often preoccupied with the elusive fountain
Decoding the 100-Year-Old Code: Inside an Ambitious Quest to Unveil the Genetics of Extreme Longevity
In a world obsessed with youth, some scientists are turning
The Billionaire Longevity Experiment: A Cruise Ship Promises to Extend Life—For a Price
For the wealthy and the wellness-obsessed, the pursuit of longevity
Manulife and World Economic Forum Launch Longevity Innovation Challenge
Manulife and World Economic Forum Launch Longevity Innovation Challenge In
Debate Highlights: Can Aging Be Halted or Reversed? Experts Weigh In
Debating the Future: Can Aging Be Halted or Reversed? Introduction
MOST POPULAR
